Bayer Stock Price, News & Analysis (FRA:BAYN)

€99.20 +1.41 (+1.44 %)
(As of 02/20/2018 04:00 PM ET)
Previous Close€99.20
Today's Range€97.62 - €99.20
52-Week Range€93.30 - €123.82
Volume1,019 shs
Average VolumeN/A
Market Capitalization$82.02 billion
P/E Ratio23.45
Dividend Yield2.72%
BetaN/A

About Bayer (FRA:BAYN)

Bayer logoBayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, Crop Science, Animal Health, and Covestro segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents. The Consumer Health segment provides nonprescription over-the-counter products in the dermatology, nutritional supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care, and sun protection categories. The Crop Science segment offers products in the areas of seeds and plant traits, crop protection, and nonagricultural pest control. The Animal Health segment provides prescription and nonprescription veterinary products. The Covestro segment provides raw materials for polyurethanes; polycarbonate granules and sheets; and raw materials for coatings, adhesives, and sealants; and by-products of polyether production and of chlorine production and use. The company has strategic partnerships with Broad Institute and German Cancer Research Center, as well as strategic research alliance with University of Oxford; and a multi-target endometriosis alliance with Evotec AG. It also has a strategic alliance with Rothamsted Research; and a research agreement with Vanderbilt University Medical Center to develop therapies for kidney diseases. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.

Receive BAYN News and Ratings via Email

Sign-up to receive the latest news and ratings for BAYN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorHealthcare
SymbolFRA:BAYN
CUSIPN/A
Phone+49-214-301

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E Ratio23.451536643026
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding Shares826,950,000

Bayer (FRA:BAYN) Frequently Asked Questions

What is Bayer's stock symbol?

Bayer trades on the FRA under the ticker symbol "BAYN."

Where is Bayer's stock going? Where will Bayer's stock price be in 2018?

20 equities research analysts have issued 12 month price targets for Bayer's shares. Their forecasts range from €100.00 to €140.00. On average, they expect Bayer's stock price to reach €122.42 in the next twelve months. View Analyst Ratings for Bayer.

Who are some of Bayer's key competitors?

Who are Bayer's key executives?

Bayer's management team includes the folowing people:

  • Werner Wenning, Chairman of the Supervisory Board (Age 71)
  • Werner Baumann, Chairman of the Management Board, Chief Executive Officer (Age 54)
  • Oliver Zuehlke, Vice Chairman of the Supervisory Board, Employee Representative (Age 48)
  • Johannes M. Dietsch, Chief Financial Officer, Member of the Management Board (Age 55)
  • Hartmut Klusik, Member of the Management Board, Director of Human Resources, Technology & Sustainability, Labor Director (Age 60)
  • Jennifer Brendelto, Vice President - Communications of the Consumer Health Division
  • Liam Condon, Member of the Management Board, Head of the Crop Science Division, Animal Health Business Unit (Age 48)
  • Kemal Malik, Member of the Management Board, Innovation and the Latin America Region (Age 54)
  • Erica Mann, Member of the Management Board, Head of the Consumer Health Division (Age 59)
  • Dieter Weinand, Member of the Management Board, Head of the Pharmaceuticals Division (Age 56)

What is Bayer's stock price today?

One share of Bayer stock can currently be purchased for approximately €99.20.

How big of a company is Bayer?

Bayer has a market capitalization of $82.02 billion.

How can I contact Bayer?

Bayer's mailing address is Kaiser-Wilhelm-Allee 1, LEVERKUSEN, 51373, Germany. The healthcare company can be reached via phone at +49-214-301.


MarketBeat Community Rating for Bayer (BAYN)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  952 (Vote Outperform)
Underperform Votes:  711 (Vote Underperform)
Total Votes:  1,663
MarketBeat's community ratings are surveys of what our community members think about Bayer and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Bayer (FRA:BAYN) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.602.602.602.62
Ratings Breakdown: 1 Sell Rating(s)
6 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
6 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
6 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
8 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: €122.42€122.42€123.21€120.20

Bayer (FRA:BAYN) Consensus Price Target History

Price Target History for Bayer (FRA:BAYN)

Bayer (FRA:BAYN) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
2/16/2018CitigroupReiterated RatingBuyView Rating Details
2/6/2018Baader BankSet Price TargetBuy€140.00View Rating Details
2/2/2018Sanford C. BernsteinSet Price TargetBuy€129.00View Rating Details
1/30/2018JPMorgan Chase & Co.Set Price TargetBuy€128.00View Rating Details
1/24/2018DZ BankReiterated RatingBuyView Rating Details
1/23/2018Goldman Sachs GroupSet Price TargetBuy€125.00View Rating Details
1/22/2018BarclaysSet Price TargetSell€100.00View Rating Details
1/19/2018Deutsche BankSet Price TargetBuy€125.00View Rating Details
1/16/2018Jefferies GroupSet Price TargetBuy€125.00View Rating Details
1/12/2018Independent ResearchSet Price TargetNeutral€120.00View Rating Details
1/11/2018Warburg ResearchSet Price TargetNeutral€121.00View Rating Details
1/9/2018CommerzbankSet Price TargetBuy€124.00View Rating Details
1/2/2018Nord/LBReiterated RatingNeutralView Rating Details
12/5/2017Berenberg BankSet Price TargetNeutral€124.00View Rating Details
11/14/2017Societe GeneraleSet Price TargetNeutral€117.00View Rating Details
10/26/2017S&P GlobalSet Price TargetBuy€126.00View Rating Details
10/26/2017equinetSet Price TargetBuy€118.00View Rating Details
9/25/2017BNP ParibasSet Price TargetBuy€130.00View Rating Details
8/28/2017Kepler Capital MarketsSet Price TargetNeutral€102.00View Rating Details
6/12/2017Bank of AmericaSet Price TargetBuy€140.00View Rating Details
11/9/2016Bankhaus LampeSet Price TargetBuy€103.00View Rating Details
10/26/2016S&P GlobalSet Price TargetBuy€120.00View Rating Details
4/27/2016Morgan StanleySet Price TargetSell€105.00View Rating Details
4/27/2016Credit Suisse GroupSet Price TargetNeutral€117.00View Rating Details
(Data available from 2/20/2016 forward)

Earnings

Earnings History for Bayer (FRA:BAYN)


No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Bayer (FRA:BAYN) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Bayer (FRA:BAYN)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Bayer (FRA BAYN)

No insider trades for this company have been tracked by MarketBeat.com

Headlines

Bayer (FRA BAYN) News Headlines

Source:
DateHeadline
Covestro profit quadruples on higher pricesCovestro profit quadruples on higher prices
www.marketwatch.com - February 20 at 9:06 AM
Bayer (BAYN) Receives "Buy" Rating from CitigroupBayer (BAYN) Receives "Buy" Rating from Citigroup
www.americanbankingnews.com - February 16 at 9:52 AM
Baby Berkshire Bets on Mergers Reshaping Key IndustriesBaby Berkshire Bets on Mergers Reshaping Key Industries
finance.yahoo.com - February 15 at 4:34 PM
Bayer gets FDA warning over German manufacturingBayer gets FDA warning over German manufacturing
www.marketwatch.com - February 14 at 4:47 PM
Bayer gets FDA rebuke for drug production in GermanyBayer gets FDA rebuke for drug production in Germany
finance.yahoo.com - February 14 at 9:09 AM
Bayer (BAYN) Given a €125.00 Price Target at UBS GroupBayer (BAYN) Given a €125.00 Price Target at UBS Group
www.americanbankingnews.com - February 12 at 9:34 AM
Bayer (BAYN) Given a €125.00 Price Target by UBS Group AnalystsBayer (BAYN) Given a €125.00 Price Target by UBS Group Analysts
www.americanbankingnews.com - February 5 at 11:32 AM
The Gene-Tech Stock That Will Modify Your PortfolioThe Gene-Tech Stock That Will Modify Your Portfolio
www.forbes.com - February 5 at 9:08 AM
Bayer offers new concessions to win EU approval for Monsanto dealBayer offers new concessions to win EU approval for Monsanto deal
finance.yahoo.com - February 5 at 9:08 AM
Bayer (BAYN) PT Set at €129.00 by Sanford C. BernsteinBayer (BAYN) PT Set at €129.00 by Sanford C. Bernstein
www.americanbankingnews.com - February 3 at 10:24 PM
Bayer AG (BAYN) Given Average Recommendation of "Buy" by BrokeragesBayer AG (BAYN) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - February 3 at 9:36 PM
Bayer (BAYN) PT Set at €125.00 by UBS GroupBayer (BAYN) PT Set at €125.00 by UBS Group
www.americanbankingnews.com - January 29 at 8:22 AM
Bayer (BAYN) Receives "Buy" Rating from DZ BankBayer (BAYN) Receives "Buy" Rating from DZ Bank
www.americanbankingnews.com - January 24 at 9:06 PM
Bayer (BAYN) PT Set at €125.00 by Goldman Sachs GroupBayer (BAYN) PT Set at €125.00 by Goldman Sachs Group
www.americanbankingnews.com - January 24 at 12:08 AM
Bayer (BAYN) PT Set at €100.00 by BarclaysBayer (BAYN) PT Set at €100.00 by Barclays
www.americanbankingnews.com - January 22 at 12:04 PM
Bayer (BAYN) PT Set at €125.00 by Deutsche BankBayer (BAYN) PT Set at €125.00 by Deutsche Bank
www.americanbankingnews.com - January 19 at 6:52 AM
Citigroup Reaffirms Buy Rating for Bayer (BAYN)Citigroup Reaffirms Buy Rating for Bayer (BAYN)
www.americanbankingnews.com - January 17 at 8:32 AM
Bayer (BAYN) Given a €125.00 Price Target by Jefferies Group AnalystsBayer (BAYN) Given a €125.00 Price Target by Jefferies Group Analysts
www.americanbankingnews.com - January 16 at 8:44 AM
Bayer (BAYN) Earns "Buy" Rating from UBS GroupBayer (BAYN) Earns "Buy" Rating from UBS Group
www.americanbankingnews.com - January 15 at 11:02 AM
Bayer (BAYN) Given a €120.00 Price Target by Independent Research AnalystsBayer (BAYN) Given a €120.00 Price Target by Independent Research Analysts
www.americanbankingnews.com - January 13 at 10:26 PM
Bayer cuts direct Covestro stake to 14.2% - MarketWatchBayer cuts direct Covestro stake to 14.2% - MarketWatch
www.marketwatch.com - January 12 at 3:44 PM
Bayer AG (BAYN) Given Average Rating of "Buy" by BrokeragesBayer AG (BAYN) Given Average Rating of "Buy" by Brokerages
www.americanbankingnews.com - January 9 at 11:44 PM
Bayer (BAYN) PT Set at €131.00 by Sanford C. BernsteinBayer (BAYN) PT Set at €131.00 by Sanford C. Bernstein
www.americanbankingnews.com - January 4 at 9:00 AM
Sanford C. Bernstein Reiterates "€131.00" Price Target for Bayer (BAYN)Sanford C. Bernstein Reiterates "€131.00" Price Target for Bayer (BAYN)
www.americanbankingnews.com - December 31 at 9:46 AM
Bayer (BAYN) PT Set at €125.00 by JPMorgan Chase & Co.Bayer (BAYN) PT Set at €125.00 by JPMorgan Chase & Co.
www.americanbankingnews.com - December 30 at 8:56 PM
JPMorgan Chase & Co. Reiterates €128.00 Price Target for Bayer (BAYN)JPMorgan Chase & Co. Reiterates €128.00 Price Target for Bayer (BAYN)
www.americanbankingnews.com - December 29 at 2:12 PM
Nord/LB Reaffirms Neutral Rating for Bayer (BAYN)Nord/LB Reaffirms Neutral Rating for Bayer (BAYN)
www.americanbankingnews.com - December 27 at 8:09 AM
Bayer (BAYN) Given a €100.00 Price Target at BarclaysBayer (BAYN) Given a €100.00 Price Target at Barclays
www.americanbankingnews.com - December 25 at 10:06 AM
Bayer AG (BAYN) Given Consensus Rating of "Buy" by BrokeragesBayer AG (BAYN) Given Consensus Rating of "Buy" by Brokerages
www.americanbankingnews.com - December 15 at 7:43 PM
Baader Bank Analysts Give Bayer (BAYN) a €140.00 Price TargetBaader Bank Analysts Give Bayer (BAYN) a €140.00 Price Target
www.americanbankingnews.com - December 14 at 8:30 AM
DZ Bank Reiterates Buy Rating for Bayer (BAYN)DZ Bank Reiterates Buy Rating for Bayer (BAYN)
www.americanbankingnews.com - December 11 at 6:32 PM
Nord/LB Analysts Give Bayer (BAYN) a €102.00 Price TargetNord/LB Analysts Give Bayer (BAYN) a €102.00 Price Target
www.americanbankingnews.com - December 8 at 10:34 AM
UBS Analysts Give Bayer (BAYN) a €125.00 Price TargetUBS Analysts Give Bayer (BAYN) a €125.00 Price Target
www.americanbankingnews.com - December 7 at 10:38 AM
Bayer (BAYN) Given Buy Rating at CitigroupBayer (BAYN) Given Buy Rating at Citigroup
www.americanbankingnews.com - December 7 at 10:38 AM
Barclays Analysts Give Bayer (BAYN) a €100.00 Price TargetBarclays Analysts Give Bayer (BAYN) a €100.00 Price Target
www.americanbankingnews.com - December 6 at 6:27 PM
Berenberg Bank Reiterates €124.00 Price Target for Bayer (BAYN)Berenberg Bank Reiterates €124.00 Price Target for Bayer (BAYN)
www.americanbankingnews.com - December 5 at 6:18 AM
Bayer (BAYN) PT Set at €120.00 by Independent ResearchBayer (BAYN) PT Set at €120.00 by Independent Research
www.americanbankingnews.com - November 28 at 9:54 AM
Bayer AG (BAYN) Given a €125.00 Price Target by UBS AG AnalystsBayer AG (BAYN) Given a €125.00 Price Target by UBS AG Analysts
www.americanbankingnews.com - November 27 at 9:30 AM
Jefferies Group LLC Analysts Give Bayer AG (BAYN) a €137.00 Price TargetJefferies Group LLC Analysts Give Bayer AG (BAYN) a €137.00 Price Target
www.americanbankingnews.com - November 25 at 6:50 PM
Bayers (BAYN) "Buy" Rating Reiterated at DZ Bank AGBayer's (BAYN) "Buy" Rating Reiterated at DZ Bank AG
www.americanbankingnews.com - November 25 at 2:52 PM
Bayer AG (BAYN) Given Consensus Rating of "Buy" by AnalystsBayer AG (BAYN) Given Consensus Rating of "Buy" by Analysts
www.americanbankingnews.com - November 20 at 7:52 PM
PeptiDream Announces Discovery Collaboration Agreement with Bayer - Business Wire (press release)PeptiDream Announces Discovery Collaboration Agreement with Bayer - Business Wire (press release)
www.businesswire.com - November 20 at 2:14 AM
Bayer AG (BAYN) Given a €105.00 Price Target at Barclays PLCBayer AG (BAYN) Given a €105.00 Price Target at Barclays PLC
www.americanbankingnews.com - November 17 at 11:48 AM
Bayer AG (BAYN) PT Set at €131.00 by Sanford C. BernsteinBayer AG (BAYN) PT Set at €131.00 by Sanford C. Bernstein
www.americanbankingnews.com - November 15 at 7:06 PM
Commerzbank Ag Analysts Give Bayer AG (BAYN) a €124.00 Price TargetCommerzbank Ag Analysts Give Bayer AG (BAYN) a €124.00 Price Target
www.americanbankingnews.com - November 15 at 7:14 AM
Bayer AG (BAYN) Given a €117.00 Price Target at Societe GeneraleBayer AG (BAYN) Given a €117.00 Price Target at Societe Generale
www.americanbankingnews.com - November 14 at 12:26 PM
Barclays PLC Analysts Give Bayer AG (BAYN) a €105.00 Price TargetBarclays PLC Analysts Give Bayer AG (BAYN) a €105.00 Price Target
www.americanbankingnews.com - November 6 at 4:18 PM
Bayer AG (BAYN) PT Set at €124.00 by Berenberg BankBayer AG (BAYN) PT Set at €124.00 by Berenberg Bank
www.americanbankingnews.com - November 3 at 1:00 PM
Bayer, Novartis clash with UK doctors over use of cheap eye drugBayer, Novartis clash with UK doctors over use of cheap eye drug
finance.yahoo.com - October 31 at 10:36 PM
Bayer AG (BAYN) PT Set at €124.00 by Deutsche Bank AGBayer AG (BAYN) PT Set at €124.00 by Deutsche Bank AG
www.americanbankingnews.com - October 27 at 6:26 AM

SEC Filings

Bayer (FRA:BAYN) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Social activity is not available for this stock.

Financials

Financials are not available for this stock.

Chart

Bayer (FRA BAYN) Stock Chart for Tuesday, February, 20, 2018

Loading chart…

This page was last updated on 2/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.